表紙:ゲルドキュメンテーションシステムの世界市場 (2021-2030年):市場予測 (製品・光源・検出技術・用途・エンドユーザー別)・国別データ (16カ国)・競合環境
市場調査レポート
商品コード
1023010

ゲルドキュメンテーションシステムの世界市場 (2021-2030年):市場予測 (製品・光源・検出技術・用途・エンドユーザー別)・国別データ (16カ国)・競合環境

Global Gel Documentation Systems Market: Focus on Products, Source of Light, Detection Technology, Application, End User, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2021-2030

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=116.46円
ゲルドキュメンテーションシステムの世界市場 (2021-2030年):市場予測 (製品・光源・検出技術・用途・エンドユーザー別)・国別データ (16カ国)・競合環境
出版日: 2021年08月12日
発行: BIS Research Inc.
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲルドキュメンテーションシステムの市場規模は予測期間中4.04%のCAGRで推移し、2030年には4億1110万米ドルの規模に成長すると予測されています。

遺伝性疾患の有病率の上昇、ゲノミクス部門の研究資金の増加、人口ゲノミクスへの取り組みの増加などの要因が同市場の成長を推進しています。一方で、複雑性の高いゲノム検査センターの不足、ゲノムデータの保存に関する課題、高度な診断能力に関連する知識の普及不足などの課題が市場のさらなる成長を妨げています。

当レポートでは、世界のゲルドキュメンテーションシステムの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、製品・光源・検出技術・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

第1章 製品の定義

第2章 市場の範囲

第3章 調査手法

第4章 市場概要

第5章 市場力学

  • 概要
  • 影響分析
  • 市場推進要因
  • 市場抑制要因
  • 市場機会

第6章 産業考察

  • 概要
  • 法的要件・枠組み:米国
  • 法的要件・枠組み:欧州
  • 法的要件・枠組み:アジア太平洋

第7章 競合情勢

  • 買収
  • 製品の発売・アップグレード
  • 市場シェア分析:企業別
  • 成長シェア分析

第8章 市場分析・予測:製品別

  • 機器
  • 付属品
  • ソフトウェア

第9章 市場分析・予測:光源別

  • UV
  • LED
  • レーザー
  • その他

第10章 市場分析・予測:検出技術別

  • 蛍光
  • 化学発光
  • 比色
  • その他

第11章 市場分析・予測:用途別

  • 核酸の定量化
  • タンパク質の定量化
  • その他

第12章 市場分析・予測:エンドユーザー別

  • 学術・研究機関
  • 病院・診断ラボ
  • 製薬・バイオテクノロジー企業
  • CRO
  • その他

第13章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第14章 企業プロファイル

  • Analytik Jena GmbH
  • Azure Biosystems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cleaver Scientific
  • Clinx Science Instruments Co., Ltd.
  • Danaher Corporation
  • Endress+Hauser Group
  • LI-COR, Inc.
  • Merck KGaA
  • NIPPON Genetics Europe
  • PerkinElmer, Inc.
  • Syngene
  • Thermo Fisher Scientific Inc.
  • Vilber
図表

List of Tables

  • Table 5.1: Likert Scale
  • Table 5.2: Impact Analysis of Market Drivers
  • Table 5.3: Impact Analysis of Market Restraints
  • Table 8.1: Instruments Offered by Key Players
  • Table 8.2: Accessories Offered by Key Players
  • Table 8.2: Software Offered by Key Players
  • Table 9.1: Instruments Based on UV Light Source
  • Table 9.2: Instruments Based on LEDs Light Source
  • Table 9.3: Instruments Based on Laser Source
  • Table 9.4: Instruments Based on Other Sources

List of Figures

  • Figure 1: Annual NIH Funding in Human Genomics Research, FY2013-FY2019, $ Billion
  • Figure 2: Impact Analysis of Market Drivers and Market Challenges on Global Gel Documentation Systems Market
  • Figure 3: Global Gel Documentation Systems Market (by Products), $Million, 2020 vs. 2030
  • Figure 4: Global Gel Documentation Systems Market (by Detection Technology), $Million, 2020 vs. 2030
  • Figure 5: Global Gel Documentation Systems Market (by Application), $Million, 2020 vs. 2030
  • Figure 6: Global Gel Documentation Systems Market (by End User), $Million, 2020 vs. 2030
  • Figure 7: Global Gel Documentation Systems Market Snapshot
  • Figure 2.1: Global Gel Documentation Systems Market: Segmentation
  • Figure 3.1: Global Gel Documentation Systems Market: Research Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Global Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 4.2: Global Gel Documentation Systems Market: COVID-19 Impact
  • Figure 5.1: Number of Patients Suffering from Cystic Fibrosis (CF), 2002-2019
  • Figure 6.1: FDA IVD Classification and Regulatory Process
  • Figure 6.2: Key Changes in EU IVD Regulation 2017/746
  • Figure 6.3: Medical Device Regulatory Approval Process in China
  • Figure 7.1: Share of Acquisitions (by Company), January 2017-May 2021
  • Figure 7.2: Number of Product Launches and Upgradations (by Company), January 2017-July 2021
  • Figure 7.3: Market Share Analysis for Global Gel Documentation Systems Market, 2020
  • Figure 7.4: Growth Share Analysis for Global Gel Documentation Systems Market (by Detection Technology), 2020-2031
  • Figure 8.1: Global Gel Documentation Systems Market (by Products)
  • Figure 8.2: Global Gel Documentation Systems Market (by Products), 2020-2030
  • Figure 8.3: Global Gel Documentation Systems Market (Instruments), $Million, 2020-2030
  • Figure 8.4: Global Gel Documentation Systems Market (by Instruments), 2020-2030
  • Figure 8.5: Global Gel Documentation Systems Market (Accessories), $Million, 2020-2030
  • Figure 8.6: Global Gel Documentation Systems Market (Software), $Million, 2020-2030
  • Figure 9.1: Global Gel Documentation Systems Market (by Source of Light)
  • Figure 9.2: Global Gel Documentation Systems Market (by Source of Light), $Million, 2020-2030
  • Figure 9.3: Global Gel Documentation Systems Market (UV), $Million, 2020-2030
  • Figure 9.4: Global Gel Documentation Systems Market (LEDs), $Million, 2020-2030
  • Figure 9.5: Global Gel Documentation Systems Market (Laser), $Million, 2020-2030
  • Figure 9.6: Global Gel Documentation Systems Market (Other Sources), $Million, 2020-2030
  • Figure 10.1: Global Gel Documentation Systems Market (by Detection Technology)
  • Figure 10.2: Global Gel Documentation Systems Market (by Detection Technology), 2020-2030
  • Figure 10.3: Global Gel Documentation Systems Market (Fluorescence), $Million, 2020-2030
  • Figure 10.4: Global Gel Documentation Systems Market (Chemiluminescence), $Million, 2020-2030
  • Figure 10.5: Global Gel Documentation Systems Market (Colorimetric), $Million, 2020-2030
  • Figure 10.6: Global Gel Documentation Systems Market (Other Detection Technologies), $Million, 2020-2030
  • Figure 11.1: Global Gel Documentation Systems Market (by Application)
  • Figure 11.2: Global Gel Documentation Systems Market (by Application), $Million, 2020-2030
  • Figure 11.3: Global Gel Documentation Systems Market (Nucleic Acid Quantification), $Million, 2020-2030
  • Figure 11.4: Global Gel Documentation Systems Market (Protein Quantification), $Million, 2020-2030
  • Figure 11.5: Global Gel Documentation Systems Market (Other Applications), $Million, 2020-2030
  • Figure 12.1: Global Gel Documentation Systems Market (by End User)
  • Figure 12.2: Global Gel Documentation Systems Market (by End User), $Million, 2020-2030
  • Figure 12.3: Global Gel Documentation Systems Market (Academic and Research Institutions), $Million, 2020-2030
  • Figure 12.4: Global Gel Documentation Systems Market (Hospitals and Diagnostic Laboratories), $Million, 2020-2030
  • Figure 12.5: Global Gel Documentation Systems Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2030
  • Figure 12.6: Global Gel Documentation Systems Market (Contract Research Organization), $Million, 2020-2030
  • Figure 12.7: Global Gel Documentation Systems Market (Other End Users), $Million, 2020-2030
  • Figure 13.1: Global Gel Documentation Systems Market (by Region), 2020 and 2030
  • Figure 13.2: Global Gel Documentation Systems Market (by Region), $Million, 2020-2030
  • Figure 13.3: Global Gel Documentation Systems Market (by Region), 2020-2030
  • Figure 13.4: North America Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.5: North America: Market Dynamics
  • Figure 13.6: North America Gel Documentation Systems Market (by Country), $Million, 2020-2030
  • Figure 13.7: U.S. Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.8: Canada Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.9: Europe Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.10: Europe: Market Dynamics
  • Figure 13.11: Europe Gel Documentation Systems Market (by Country), $Million, 2020-2030
  • Figure 13.12: Germany Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.13: U.K. Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.14: France Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.15: Italy Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.16: Spain Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.17: Switzerland Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.18: Rest-of-Europe Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.19: Asia-Pacific Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.20: APAC: Market Dynamics
  • Figure 13.21: APAC Gel Documentation Systems Market (by Country), $Million, 2020-2030
  • Figure 13.22: China Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.23: India Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.24: Japan Gel documentation Systems Market, $Million, 2020-2030
  • Figure 13.25: Australia Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.26: South Korea Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.27: Singapore Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.28: RoAPAC Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.29: Latin America Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.30: Latin America: Market Dynamics
  • Figure 13.31: Latin America Gel Documentation Systems Market (by Country), $Million, 2020-2030
  • Figure 13.32: Brazil Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.33: Mexico Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.34: Rest-of-Latin America Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 13.35: RoW Gel Documentation Systems Market, $Million, 2020-2030
  • Figure 14.1: Total Number of Companies Profiled
  • Figure 14.2: Analytik Jena GmbH: Key Product Portfolio
  • Figure 14.3: Analytik Jena GmbH: SWOT Analysis
  • Figure 14.4: Azure Biosystems, Inc.: Product Portfolio
  • Figure 14.5: Azure Biosystems, Inc.: SWOT Analysis
  • Figure 14.6: Bio-Rad Laboratories, Inc.: Product Portfolio
  • Figure 14.7: Bio-Rad Laboratories, Inc.: Overall Financials, 2018-2020
  • Figure 14.8: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2018-2020
  • Figure 14.9: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2018-2020
  • Figure 14.10: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2018-2020
  • Figure 14.11: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 14.12: Bio-Techne Corporation: Product Portfolio
  • Figure 14.13: Bio-Techne Corporation: Overall Financials, 2018-2020
  • Figure 14.14: Bio-Techne Corporation: Revenue (by Segment), 2018-2020
  • Figure 14.15: Bio-Techne Corporation: Revenue (by Region), 2018-2020
  • Figure 14.16: Bio-Techne Corporation: R&D Expenditure, 2018-2020
  • Figure 14.17: Bio-Techne Corporation: SWOT Analysis
  • Figure 14.18: Cleaver Scientific: Product Portfolio
  • Figure 14.19: Cleaver Scientific: SWOT Analysis
  • Figure 14.20: Clinx Science Instruments Co., Ltd.: Product Portfolio
  • Figure 14.21: Clinx Science Instruments Co., Ltd.: SWOT Analysis
  • Figure 14.22: Danaher Corporation: Product Portfolio
  • Figure 14.23: Danaher Corporation: Overall Financials, 2018-2020
  • Figure 14.24: Danaher Corporation: Revenue (by Segment), 2018-2020
  • Figure 14.25: Danaher Corporation: Revenue (by Region), 2018-2020
  • Figure 14.26: Danaher Corporation: R&D Expenditure, 2018-2020
  • Figure 14.27: Danaher Corporation: SWOT Analysis
  • Figure 14.28: Endress + Hauser Group: Overall Financials, 2018-2020
  • Figure 14.29: Endress + Hauser Group: Revenue (by Segment), 2018-2020
  • Figure 14.30: Endress + Hauser Group: Revenue (by Region), 2018-2020
  • Figure 14.31: Endress + Hauser Group: R&D Expenditure, 2018-2020
  • Figure 14.32: Endress + Hauser Group: SWOT Analysis
  • Figure 14.33: LI-COR, Inc.: Product Portfolio
  • Figure 14.34: LI-COR, Inc.: SWOT Analysis
  • Figure 14.35: Merck KGaA: Key Product Offerings
  • Figure 14.36: Merck KGaA: Overall Financials, 2018-2020
  • Figure 14.37: Merck KGaA: Revenue (by Segment), $Million, 2018-2020
  • Figure 14.38: Merck KGaA: Revenue (by Region), 2018-2020
  • Figure 14.39: Merck KGaA: R&D Expenditure, 2018-2020
  • Figure 14.40: Merck KGaA: SWOT Analysis
  • Figure 14.41: NIPPON Genetics Europe: Key Product Portfolio
  • Figure 14.42: NIPPON Genetics Europe: SWOT Analysis
  • Figure 14.43: PerkinElmer, Inc.: Key Product Portfolio
  • Figure 14.44: Perkin Elmer, Inc.: Overall Financials, (2018-2020)
  • Figure 14.45: Perkin Elmer, Inc.: Revenue (by Segment), 2018-2020
  • Figure 14.46: Perkin Elmer, Inc.: Revenue (by Region), 2018-2020
  • Figure 14.47: PerkinElmer, Inc.: R&D Expenditure, 2018-2020
  • Figure 14.48: PerkinElmer, Inc.: SWOT Analysis
  • Figure 14.49: Syngene: Product Portfolio
  • Figure 14.50: Syngene: SWOT Analysis
  • Figure 14.51: Thermo Fisher Scientific, Inc.: Product Portfolio
  • Figure 14.52: Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020
  • Figure 14.53: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2018-2020
  • Figure 14.54: Thermo Fisher Scientific Inc.: Revenue (by Region), 2018-2020
  • Figure 14.55: Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020
  • Figure 14.56: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 14.57: Vilber: Product Portfolio
  • Figure 14.58: Vilber.: SWOT Analysis
目次
Product Code: BHP1087SA

“Global Gel Documentation Systems Market to Reach $411.1 Million by 2030.”

Market Report Coverage - Gel Documentation Systems

Market Segmentation

  • Products (Instruments, Accessories, and Software)
  • Source of Light (Ultraviolet, Light Emitting Diodes, Laser and Others)
  • Detection Technology (Fluorescence, Chemiluminescence, Colorimetric, and Other Detection Technologies)
  • Application (Nucleic Acid Quantification, Protein Quantification, and Other Applications)
  • End User (Academic and Research Institutions, Hospitals and Diagnostics Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organization and Other End Users)

Regional Segmentation

  • North America: U.S., Canada
  • Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of-Europe
  • Asia-Pacific: Japan, China, India, Australia, South Korea, Singapore, and Rest-of-APAC
  • Latin America: Brazil, Mexico, Rest-of-Latin America
  • Rest-of-the-World (RoW)

Market Growth Drivers

  • Rising Prevalence of Genetic Disorders
  • Increasing Research Funding in the Field of Genomics
  • Increasing Number of Population Genomics Initiatives

Market Challenges

  • Lack of High Complexity Genomic Testing Centers in High Potential Markets
  • Challenges Pertaining to Genomic Data Centers
  • Scarcity of Knowledge Dissemination Pertaining to Advanced Diagnostic Capabilities

Market Opportunities

  • Massive Scope for Adoption of Genomic Data Analysis Software in Emerging Nations
  • Novel Diagnostic Applications

Key Companies Profiled

Analytik Jena GmbH, Azure Biosystems, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cleaver Scientific, Clinx Science Instruments Co., Ltd., Danaher Corporation, Endress + Hauser Group, LI-COR, Inc., Merck KGaA, NIPPON Genetics Europe, PerkinElmer, Inc., Syngene, Thermo Fisher Scientific Inc., Vilber.

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global gel documentation systems market?
  • What are the underlying structures resulting in the emerging trends within the global gel documentation systems market?
  • How is the COVID-19 pandemic impacting the global gel documentation systems market landscape?
  • What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
  • What are the key regulatory implications in developed and developing regions pertaining to gel documentation systems?
  • What are the potential entry barriers, which are expected to be faced by the companies willing to enter a particular region for the development of gel documentation systems?
  • How is each segment of the market expected to grow during the forecast period 2021-2030, and what is the anticipated revenue to be generated by each segment? Following are the segments:
    • Products (instruments, accessories, and software)
    • Source of light (UV, LEDs, laser, and others)
    • Detection Technology (fluorescence, chemiluminescence, colorimetric, and other detection technologies)
    • Application (nucleic acid quantification, protein quantification, and other applications)
    • End user (academic and research institutions, hospitals and diagnostics laboratories, pharmaceutical and biotechnology companies, contract research organization, and other end users)
    • Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
  • What are the growth opportunities for the companies in the region of their operation?
  • Who are the leading players with significant offerings in the global gel documentation systems market?
  • Which companies are anticipated to be highly disruptive in the future, and why?
  • What are the current unmet needs that are being faced in the global gel documentation systems market?

Market Overview

Gel documentation systems are used to image labeled protein samples and nucleic acid samples. Further, gel documentation systems are processed in a variety of configurations depending on throughput and sample type. Gel documentation systems measure labeled nucleic acid and protein in various types of media such as cellulose, agarose, or acrylamide. These systems come in a variety of configurations depending on sample type.

Our healthcare experts have found the gel documentation systems market to be one of the stable markets, and the global market is predicted to grow at a CAGR of 4.04% during the forecast period 2021-2030.

Factors fueling the growth of the market include the rising prevalence of genetic disorders, the increasing research funding in the field of genomics, and the growing number of population genomics initiatives. Despite rapid advanced industry growth, several key issues need to be addressed to facilitate future growth. The lack of high complexity genomic testing centers in high potential markets, challenges pertaining to genomic data storage, and scarcity of knowledge dissemination pertaining to advanced diagnostic capabilities are hampering the market growth. Further, some of the opportunities, such as massive scope for genomic data analysis software adoption in emerging nations, provide growth to the market.

Within the research report, the market has been segmented on the basis of products, source of light, detection technology, application, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in genetic disorders on the global level has created a buzz among companies to invest in advanced technologies such as gel documentation systems.

Based on region, North America holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific and Europe regions are anticipated to grow at the fastest CAGR during the forecast period.

Table of Contents

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Market Scope

  • 2.1 Scope of the Study
  • 2.2 Key Questions Answered in this Report

3 Research Methodology

  • 3.1 Global Gel Documentation Systems Market: Research Methodology
  • 3.2 Data Sources
    • 3.2.1 Primary Data Sources
    • 3.2.2 Secondary Data Sources
  • 3.3 Market Estimation Model
  • 3.4 Criteria for Company Profiling

4 Market Overview

  • 4.1 Market Definition
  • 4.2 Market Footprint and Growth Potential
  • 4.3 COVID-19 Impact on Global Gel Documentation Systems Market

5 Market Dynamics

  • 5.1 Overview
  • 5.2 Impact Analysis
  • 5.3 Market Drivers
    • 5.3.1 Rising Prevalence of Genetic Disorders
    • 5.3.2 Increasing Research Funding in the Field of Genomics
    • 5.3.3 Increasing Number of Population Genomics Initiatives
  • 5.4 Market Restraints
    • 5.4.1 Lack of High Complexity Genomic Testing Centers in High Potential Markets
    • 5.4.2 Challenges Pertaining to Genomic Data Storage
    • 5.4.3 Scarcity of Knowledge Dissemination Pertaining to Advanced Diagnostic Capabilities
  • 5.5 Market Opportunities
    • 5.5.1 Massive Scope for Adoption of Genomic Data Analysis Software in Emerging Nations
    • 5.5.2 Novel Diagnostic Applications

6 Industry Insights

  • 6.1 Overview
  • 6.2 Legal Requirements and Framework in the U.S.
    • 6.2.1 Food and Drug Administration (FDA) Regulation
    • 6.2.2 Centers for Medicare and Medicaid Services (CMS) Regulation
  • 6.3 Legal Requirements and Framework in Europe
  • 6.4 Legal Requirements and Framework in Asia-Pacific
    • 6.4.1 China
    • 6.4.2 Japan

7 Competitive Landscape

  • 7.1 Acquisitions
  • 7.2 Product Launches and Upgradations
  • 7.3 Market Share Analysis (by Company), 2020
  • 7.4 Growth Share Analysis
    • 7.4.1 Growth Share Analysis (by Detection Technology)

8 Global Gel Documentation Systems Market (by Products), $Million, 2020-2030

  • 8.1 Overview
  • 8.2 Instruments
  • 8.3 Accessories
  • 8.4 Software

9 Global Gel Documentation Systems Market (by Source of Light), $Million, 2020-2030

  • 9.1 Overview
  • 9.2 UV
  • 9.3 LEDs
  • 9.4 Laser
  • 9.5 Other Sources

10 Global Gel Documentation Systems Market (by Detection Technology), $Million, 2020-2030

  • 10.1 Overview
  • 10.2 Fluorescence
  • 10.3 Chemiluminescence
  • 10.4 Colorimetric
  • 10.5 Other Detection Technologies

11 Global Gel Documentation Systems Market (by Application), $Million, 2020-2030

  • 11.1 Overview
  • 11.2 Nucleic Acid Quantification
  • 11.3 Protein Quantification
  • 11.4 Other Applications

12 Global Gel Documentation Systems Market (by End User), $Million, 2020-2030

  • 12.1 Overview
  • 12.2 Academic and Research Institutions
  • 12.3 Hospitals and Diagnostic Laboratories
  • 12.4 Pharmaceutical and Biotechnology Companies
  • 12.5 Contract Research Organization
  • 12.6 Other End Users

13 Global Gel Documentation Systems Market (by Region), $Million, 2020-2030

  • 13.1 Overview
  • 13.2 North America
    • 13.2.1 U.S.
    • 13.2.2 Canada
  • 13.3 Europe
    • 13.3.1 Germany
    • 13.3.2 U.K.
    • 13.3.3 France
    • 13.3.4 Italy
    • 13.3.5 Spain
    • 13.3.6 Switzerland
    • 13.3.7 Rest-of-Europe
  • 13.4 Asia-Pacific
    • 13.4.1 China
    • 13.4.2 India
    • 13.4.3 Japan
    • 13.4.4 Australia
    • 13.4.5 South Korea
    • 13.4.6 Singapore
    • 13.4.7 Rest-of-Asia-Pacific
  • 13.5 Latin America
    • 13.5.1 Brazil
    • 13.5.2 Mexico
    • 13.5.3 Rest-of-Latin America
  • 13.6 Rest-of-the-World (RoW)

14 Company Profiles

  • 14.1 Overview
  • 14.2 Analytik Jena GmbH
    • 14.2.1 Company Overview
    • 14.2.2 Role of Analytik Jena GmbH in the Global Gel Documentation Systems Market
    • 14.2.3 SWOT Analysis
  • 14.3 Azure Biosystems, Inc.
    • 14.3.1 Company Overview
    • 14.3.2 Role of Azure Biosystems, Inc. in the Global Gel Documentation Systems Market
    • 14.3.3 SWOT Analysis
  • 14.4 Bio-Rad Laboratories, Inc.
    • 14.4.1 Company Overview
    • 14.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Gel Documentation Systems Market
    • 14.4.3 Financials
    • 14.4.4 Key Insights About Financial Health of the Company
    • 14.4.5 SWOT Analysis
  • 14.5 Bio-Techne Corporation
    • 14.5.1 Company Overview
    • 14.5.2 Role of Bio-Techne Corporation in the Global Gel Documentation Systems Market
    • 14.5.3 Financials
    • 14.5.4 Key Insights About Financial Health of the Company
    • 14.5.5 SWOT Analysis
  • 14.6 Cleaver Scientific
    • 14.6.1 Company Overview
    • 14.6.2 Role of Cleaver Scientific in the Global Gel Documentation Systems Market
    • 14.6.3 SWOT Analysis
  • 14.7 Clinx Science Instruments Co., Ltd.
    • 14.7.1 Company Overview
    • 14.7.2 Role of Clinx Science Instruments Co., Ltd. in the Global Gel Documentation Systems Market
    • 14.7.3 SWOT Analysis
  • 14.8 Danaher Corporation
    • 14.8.1 Company Overview
    • 14.8.2 Role of Danaher Corporation in the Global Gel Documentation Systems Market
    • 14.8.3 Financials
    • 14.8.4 Key Insights About Financial Health of the Company
    • 14.8.5 SWOT Analysis
  • 14.9 Endress + Hauser Group
    • 14.9.1 Company Overview
    • 14.9.2 Role of Endress + Hauser Group in the Global Gel Documentation Systems Market
    • 14.9.3 Financials
    • 14.9.4 Key Insights About Financial Health of the Company
    • 14.9.5 SWOT Analysis
  • 14.1 LI-COR, Inc.
    • 14.10.1 Company Overview
    • 14.10.2 Role of in LI-COR, Inc. in the Global Gel Documentation Systems Market
    • 14.10.3 SWOT Analysis
  • 14.11 Merck KGaA
    • 14.11.1 Company Overview
    • 14.11.2 Role of Merck KGaA in the Global Gel Documentation Systems Market
    • 14.11.3 Financials
    • 14.11.4 Key Insights About Financial Health of the Company
    • 14.11.5 SWOT Analysis
  • 14.12 NIPPON Genetics Europe
    • 14.12.1 Company Overview
    • 14.12.2 Role of NIPPON Genetics Europe in the Global Gel Documentation Systems Market
    • 14.12.3 SWOT Analysis
  • 14.13 PerkinElmer, Inc.
    • 14.13.1 Company Overview
    • 14.13.2 Role of PerkinElmer, Inc. in the Global Gel Documentation Systems Market
    • 14.13.3 Financials
    • 14.13.4 SWOT Analysis
  • 14.14 Syngene
    • 14.14.1 Company Overview
    • 14.14.2 Role of Syngene in the Global Gel Documentation Systems Market
    • 14.14.3 SWOT Analysis
  • 14.15 Thermo Fisher Scientific Inc.
    • 14.15.1 Company Overview
    • 14.15.2 Role of Thermo Fisher Scientific Inc. in the Global Gel Documentation Systems Market
    • 14.15.3 Financials
    • 14.15.4 Key Insights About Financial Health of the Company
    • 14.15.5 SWOT Analysis
  • 14.16 Vilber
    • 14.16.1 Company Overview
    • 14.16.2 Role of Vilber in the Global Gel Documentation Systems Market
    • 14.16.3 SWOT Analysis